Department of Molecular & Cellular Medicine, Texas A&M Health Science Center, College Station, TX 77843-1114, USA.
Matrix Biol. 2009 Oct;28(8):470-9. doi: 10.1016/j.matbio.2009.07.007. Epub 2009 Aug 8.
In this study, we investigated potential mechanisms through which the known anti-angiogenic factor, tissue inhibitor of metalloproteinase-3 (TIMP-3) blocks angiogenesis. As a strategy to identify TIMP-3 binding proteins, we used tandem affinity purification, employing recombinant adenoviruses constructed to deliver TIMP-3 fused to C-terminal S and His tags (TIMP-3-S-His) or TIMP-1-S-His control to endothelial cells prior to extraction. Western blotting of final eluates revealed robust binding of A Disintegrin and Metalloproteinase (ADAM) 17 and a slight association of ADAM15 to TIMP-3, but not TIMP-1 control. To confirm a functional requirement for ADAM15 and 17 in mediating angiogenic events, a model of endothelial cell invasion was utilized. Silencing of ADAM17, but not ADAM15, expression using small interfering RNA (siRNA) interfered with invasion, resulting in decreased density of invading cells and decreased invasion distance. Stable EC lines expressing short hairpin RNA directed to ADAM17 were similarly inhibited. To confirm these results, dominant negative mutants (DeltaMPs) of ADAM10, ADAM15 or ADAM17 were delivered using recombinant lentiviruses. Expression of ADAM17 DeltaMP, but not ADAM10 or ADAM15 DeltaMP, decreased invasion density and distance. Further, time-lapse analyses revealed ADAM17 DeltaMP cells exhibited far greater numbers of protruding sprouts compared to control, suggesting an inability of extended processes to retract properly. Immunofluorescence analyses revealed ADAM17 localized to bifurcations in invading sprouts. These data jointly indicate a role for ADAM17 in modulating endothelial sprouting events during angiogenesis.
在这项研究中,我们研究了已知的抗血管生成因子基质金属蛋白酶组织抑制剂-3(TIMP-3)阻断血管生成的潜在机制。作为鉴定 TIMP-3 结合蛋白的策略,我们使用串联亲和纯化,在提取之前,使用构建的表达 TIMP-3 融合 C 末端 S 和 His 标签(TIMP-3-S-His)或 TIMP-1-S-His 对照的重组腺病毒转染内皮细胞。最终洗脱物的 Western blot 显示 ADAM17 与 TIMP-3 有很强的结合,而 ADAM15 与 TIMP-3 有轻微的结合,但与 TIMP-1 对照没有结合。为了证实 ADAM15 和 17 在介导血管生成事件中的功能要求,我们利用了内皮细胞侵袭模型。用小干扰 RNA(siRNA)沉默 ADAM17,但不沉默 ADAM15 的表达,干扰了侵袭,导致侵袭细胞密度降低和侵袭距离缩短。用靶向 ADAM17 的短发夹 RNA 稳定表达的 EC 系也受到类似的抑制。为了证实这些结果,使用重组慢病毒递呈 ADAM10、ADAM15 或 ADAM17 的显性负突变体(DeltaMPs)。表达 ADAM17 DeltaMP,但不表达 ADAM10 或 ADAM15 DeltaMP,降低了侵袭细胞密度和距离。此外,延时分析显示 ADAM17 DeltaMP 细胞比对照细胞有更多的突出芽,这表明延伸过程不能正确回缩。免疫荧光分析显示 ADAM17 定位于侵袭芽的分叉处。这些数据共同表明 ADAM17 在调节血管生成过程中的内皮发芽事件中发挥作用。